Literature DB >> 21652629

Differential altered stability and transcriptional activity of ΔNp63 mutants in distinct ectodermal dysplasias.

Gareth Browne1, Rita Cipollone, Anna Maria Lena, Valeria Serra, Huiqing Zhou, Hans van Bokhoven, Volker Dötsch, Daniele Merico, Roberto Mantovani, Alessandro Terrinoni, Richard A Knight, Eleonora Candi, Gerry Melino.   

Abstract

Heterozygous mutations of p63, a key transcription factor in epithelial development, are causative in a variety of human ectodermal dysplasia disorders. Although the mutation spectrum of these disorders displays a striking genotype-phenotype association, the molecular basis for this association is only superficially known. Here, we characterize the transcriptional activity and protein stability of ΔNp63 mutants (that is, mutants of a p63 isoform that lacks the N-terminal transactivation domain) that are found in ectrodactyly-ectodermal dysplasia-cleft syndrome (EEC), ankyloblepharon-ectodermal dysplasia-clefting syndrome (AEC) and nonsyndromic split-hand/split-foot malformation (SHFM). DNA-binding and sterile alpha motif (SAM) domain mutants accumulate in the skin of EEC and AEC syndrome patients, respectively, and show extended half lives in vitro. By contrast, C-terminal mutations found in SHFM patients have half-lives similar to that of the wild-type protein. The increased half-life of EEC and AEC mutant proteins was reverted by overexpression of wild-type ΔNp63. Interestingly, the mutant proteins exhibit normal binding to and degradation by the E3 ubiquitin ligase Itch. Finally, EEC and AEC mutant proteins have reduced transcriptional activity on several skin-specific gene promoters, whereas SHFM mutant proteins are transcriptionally active. Our results, therefore, provide evidence for a regulatory feedback mechanism for p63 that links transcriptional activity to regulation of protein homeostasis by an unknown mechanism. Disruption of this regulatory mechanism might contribute to the pathology of p63-related developmental disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21652629     DOI: 10.1242/jcs.079327

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  31 in total

1.  p63-microRNA feedback in keratinocyte senescence.

Authors:  Pia Rivetti di Val Cervo; Anna Maria Lena; Milena Nicoloso; Simona Rossi; Mara Mancini; Huiqing Zhou; Gaelle Saintigny; Elena Dellambra; Teresa Odorisio; Christian Mahé; George Adrian Calin; Eleonora Candi; Gerry Melino
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-06       Impact factor: 11.205

2.  Personalized Stem Cell Therapy to Correct Corneal Defects Due to a Unique Homozygous-Heterozygous Mosaicism of Ectrodactyly-Ectodermal Dysplasia-Clefting Syndrome.

Authors:  Vanessa Barbaro; Annamaria Assunta Nasti; Paolo Raffa; Angelo Migliorati; Patrizia Nespeca; Stefano Ferrari; Elisa Palumbo; Marina Bertolin; Claudia Breda; Francesco Miceli; Antonella Russo; Luciana Caenazzo; Diego Ponzin; Giorgio Palù; Cristina Parolin; Enzo Di Iorio
Journal:  Stem Cells Transl Med       Date:  2016-05-05       Impact factor: 6.940

3.  Special AT-rich binding protein-2 (SATB2) differentially affects disease-causing p63 mutant proteins.

Authors:  Jacky Chung; R Ian Grant; David R Kaplan; Meredith S Irwin
Journal:  J Biol Chem       Date:  2011-09-29       Impact factor: 5.157

4.  Role of p63 and the Notch pathway in cochlea development and sensorineural deafness.

Authors:  Alessandro Terrinoni; Valeria Serra; Ernesto Bruno; Andreas Strasser; Elizabeth Valente; Elsa R Flores; Hans van Bokhoven; Xin Lu; Richard A Knight; Gerry Melino
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

Review 5.  Integrating animal models and in vitro tissue models to elucidate the role of desmosomal proteins in diseases.

Authors:  Maranke I Koster; Jason Dinella; Jiangli Chen; Charlene O'Shea; Peter J Koch
Journal:  Cell Commun Adhes       Date:  2014-02

6.  Impaired epithelial differentiation of induced pluripotent stem cells from ectodermal dysplasia-related patients is rescued by the small compound APR-246/PRIMA-1MET.

Authors:  Ruby Shalom-Feuerstein; Laura Serror; Edith Aberdam; Franz-Josef Müller; Hans van Bokhoven; Klas G Wiman; Huiqing Zhou; Daniel Aberdam; Isabelle Petit
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-25       Impact factor: 11.205

7.  An allelic series of Trp63 mutations defines TAp63 as a modifier of EEC syndrome.

Authors:  Emma Vernersson Lindahl; Elvin L Garcia; Alea A Mills
Journal:  Am J Med Genet A       Date:  2013-06-14       Impact factor: 2.802

8.  Genomic profiling of a human organotypic model of AEC syndrome reveals ZNF750 as an essential downstream target of mutant TP63.

Authors:  Brian J Zarnegar; Dan E Webster; Vanessa Lopez-Pajares; Brook Vander Stoep Hunt; Kun Qu; Karen J Yan; David R Berk; George L Sen; Paul A Khavari
Journal:  Am J Hum Genet       Date:  2012-08-23       Impact factor: 11.025

Review 9.  Modeling AEC-New approaches to study rare genetic disorders.

Authors:  Peter J Koch; Jason Dinella; Mary Fete; Elaine C Siegfried; Maranke I Koster
Journal:  Am J Med Genet A       Date:  2014-03-24       Impact factor: 2.802

10.  ΔNp63 targets cytoglobin to inhibit oxidative stress-induced apoptosis in keratinocytes and lung cancer.

Authors:  A Latina; G Viticchiè; A M Lena; M C Piro; M Annicchiarico-Petruzzelli; G Melino; E Candi
Journal:  Oncogene       Date:  2015-06-22       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.